Program workshopu

Program workshopu

Sunday 16.4.2023

14.00-15.00

Advisory board GSK 

(closed meeting for invited guests)

Pálava

15.00-17.00 

CMG board meeting – ongoing projects and trials

(closed meeting for CMG board and invited guests) 

Pálava

17.00-19.00 

Working groups meetings

(closed sessions for invited guests)


Flow cytometry in monoclonal gammopathies working group 

(meeting room Tramín)

Coordinator T. Jelínek

Myeloma research groups

(meeting room Müller)

Coordinator S. Ševčíková

Diagnostic methods working group – genomics and cytogenetics

(meeting room Frankovka)

Coordinator M. Jarošová

Biochemical methods working group

(meeting room Veltlín)

Coordinator J. Vávrová

Imaging in myeloma working group

(meeting room Thurgau)

Coordinator M. Havel

20.00-22.00 

Dinner

hotel Galant

Monday 17.4.2023

Morning business meetings

Müller

07.15-08.00

Biobanking project

R. Hájek + participating centers (closed session) 

08.00-09.00

CMG study investigators

R. Hájek + participating centers (closed session)

08.00-12.00 

Data management education session

(parallel to main program)

Chairs: J. Kopečková (Brno), V. Maisnar (HK), M. Štork (Brno)


8.00 - 8.45 

RMG structure - incorporated changes (IBA , Kopečková)

8.45 – 10.00 

RMG Clinical Manual - introduction + presentation of the most frequently discussed problems (Kopečková)

10.00 – 10.15 Coffee break

10.15 – 10.45 

RMG data processing process, resulting analysis (IBA)

10.45 – 11.15 

RMG summary - coordination of data entry at centers, corrections or additions to data, planned changes to the structure, control plan (Kopečková)

11.15 - 12.00 

Issues of assessment of treatment response according to FLC - specific examples (RMG working group representative)


Sauvignon


09.00-12.00 

Main program


9.00 – 9.15 Welcome and introduction (R. Hájek, Ostrava)

9.15 – 10.15 Working groups session

Chairs: R. Hájek (Ostrava), J. Minařík (Olomouc)

  • What's new in cytogenetics ? M. Jarošová et al.
  • What's new in flow ? T. Jelinek et al.
  • What's new in science ? S. Ševčíková et al.
  • What's new in biochemistry ? J. Vávrová et al.
  • What's new in PET/CT ? M. Havel et al.

10.15 – 11.45 Scientific session for clinicians

Chairs: S. Ševčíková (Brno), Z. Chyra (Ostrava)

  • The future of mass spectrometry in the diagnosis and assessment of response to treatment of MM, N. Puig (Salamanca, Spain – online) 30 min (supported by Amgen)
  • Introduction to immunotherapy, M. Šimíček (Ostrava) 15 min
  • CAR-T cells, P. Otáhal (Praha) 15 min
  • NK cells, T. Feglarová (Praha) 15 min


Aurelius

12.00-13.30 

Lunch

13.30-14.30 

Workshop - Challenges in Immunotherapy 

Chairs: R. Hájek (Ostrava), V. Maisnar (Hradec Králové)

  • Review on antibody drug conjugates, J. Minařík (Olomouc) 8 min
  • Review on bispecific antibodies, T. Jelínek (Ostrava) 8 min
  • Review on CAR-T, L. Pour (Brno) 8 min
  • Specific toxicities of CAR-T and BsAb, A. Jungová (Plzeň) 8 min
  • Infections after immunotherapy, J. Radocha (Hradec Králové) 8 min
  • Panel discussion (all)

Aurelius

14.30-15.00 

Coffee break

15.00-16.00 Industry sponsored sympozium (Takeda)


Pozice léku Ninlaro v sekvenci léčby mnohočetného myelomu

(Ninlaro position in therapy sequencing strategies in multiple myeloma)


Uvítání (Welcome)

Roman Hájek

Treatment of lenalidomide-exposed patients and position of Ninlaro in the treatment sequence (Léčba pacientů, kteří již byli léčeni lenalidomidem a pozice léku Ninlaro v léčebné sekvenci)

Karthik Ramasamy

Léčba lékem Ninlaro ve Fakultní nemocnici Ostrava (Ninlaro use in University Hospital in Ostrava)

Tereza Popková

Léčba lékem Ninlaro ve Fakultní nemocnici Brno (Ninlaro use in University Hospital Brno)

Martin Štork

Discussion (Diskuze)

Všichni (All)

Speakers:

Roman Hájek, Prof., MUDr., CSc. – FN Ostrava

Karthik Ramasamy, MBBS FRCP FRCPath PhD – Oxford University Hospitals NHS Trust

Martin Štork, MUDr., PhD. – FN Brno

Tereza Popková, MUDr. – FN Ostrava


16.10 – 17.10 Industry sponsored symposium (Janssen)


Revoluce v léčbě mnohočetného myelomu


prof. MUDr. Roman Hájek, CSc. (FN Ostrava)

MUDr. Alexandra Jungová, Ph.D. (FN Plzeň)

prof. MUDr. Vladimír Maisnar, Ph.D. (FN Hradec Králové)

doc. MUDr. et Mgr. Jiří Minařík, Ph.D. (FN Olomouc)

MUDr. Petr Pavlíček (FN Královské Vinohrady)

prof. MUDr. Luděk Pour, Ph.D. (FN Brno)

prof. MUDr. Ivan Špička, CSc. (VFN Praha)

Moderuje:

Lenka Fikrová (Janssen)


17.20 – 18.20 Industry sponsored symposium (Sanofi)


Budoucnost léčby mnohočetného myelomu


Předsedající:

doc. MUDr., Mgr. Jiří Minařík, Ph.D.


Přednášející:

Prof. MUDr. Luděk Pour, Ph.D.

Kombinace Isa+Pd je efektivní i u velice předléčených pacientů – kazuistika z reálné klinické praxe

Prof. MUDr. Roman Hájek, CSc.

Jak využití výsledků studie IKEMA může ovlivnit reálnou praxi


Aurelius

19.30-20.40 

Evening ceremony of the 21st workshop

Prof. Otto Kahler Award - doc. MUDr. Martin Mistrík, CSc

Chair: R. Hájek (Ostrava)

Mikulov castle

21.00-02.00 

Gala dinner

hotel Galant

Tuesday 18.4.2023

08.15-08.45 

Annual meeting of CMG members (CZ)

Chairs: R. Hájek (Ostrava), M. Krejčí (Brno)


  • Annual report (R. Hájek, Ostrava) 10 min
  • Steering committee report (M. Krejčí, Brno) 10 min
  • Guidelines 2023 – Multiple myeloma (R. Hajek, Ostrava) 10 min

08.45 – 09.45 Industry sponsored symposium (Amgen)

10.00 – 11.00 Workshop: Rare monoclonal gammopathies

Chairs: Z. Adam (Brno), M. Kaščák (Ostrava)

  • Overview of rare monoclonal gammopathies (Z. Adam, Brno) 15 + 5 min
  • LCDD, L. Pour (Brno), 8 + 2 min
  • POEMS, P. Kessler (Pelhřimov), 8 + 2 min
  • Schniztler syndrome, M. Sýkora (České Budějovice), 8 + 2 min
  • Localized amyloidosis, T. Pika (Olomouc), 8 + 2 min

11.10 – 12.00 New faces in myeloma: Defining response in myeloma (CZ)

Chairs: J. Ullrychová (Ústí nad Labem), M. Štork (Brno)

  • Introduction to the evaluation of treatment response in MM, M. Štork (Brno) 5 min
  • Biochemical evaluation of response in MM, F. Sedlák (VFN Praha) 8 min
  • Combined assessment of treatment response by flow cytometry and PET/CT, L. Muroňová (Ostrava) 8 min
  • PET/MRI as a new perspective method for evaluation of treatment response/MRD, V. Válek jr. (Brno KRNM) 8 min
  • Evaluation of therapeutic response in multiple myeloma in relation to RMG data entry, T. Popková (Ostrava) 8 min
  • Discussion

12.00 – 12.05 Closing comments and farewell (R. Hájek, Ostrava)

12.05 Farewell lunch

Aurelius